This list of Q&A reflects issues discussed in webinars held early in 2021.
The content has been edited, and reviewed by Waikato DHB endocrinologist/diabetologist Dr Ryan Paul.
Dr Paul is an academic endocrinologist at Waikato District Health Board and at the University of Waikato. He is an executive member of the New Zealand Society for the Study of Diabetes (NZSSD) and recently led the development of the NZSSD guidance on the management of type 2 diabetes in New Zealand. Dr Paul is heavily involved in teaching primary care clinicians, diabetes nurse prescribers and endocrinology trainees.
Presented by diabetologist Dr Ryan Paul, this recorded webinar explores:
You can find the slides from this webinar here.
More information on dulaglutide is available at:
This webinar was recorded from a live Zoom presentation hosted by Mobile Health on 25 August 2021. This video has been edited for clarity.
This activity has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 1.25 CME credits for continuing professional development purposes (1 credit per learning hour). To claim your CPD credits, log in to your Te Whanake dashboard and record these activities under the appropriate learning category.